Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 12, 2010

View Archived Issues

Electroporation can increase the efficacy of DNA vaccination for prostate cancer

MMP12 polymorphism linked to asthma and chronic obstructive pulmonary disease

Novel ER alpha and beta ligands discovered by Czech scientists

InNexus Biotechnology develops new skin-permeating psoriasis product

FDA grants fast track designation to Sopherion Therapeutics' Myocet in breast cancer

Miraculins and Inverness to collaborate on diagnostic test for pre-eclampsia

Reata and Kyowa Hakko Kirin sign licensing agreement for CKD drug bardoxolone

FDA grants marketing approval to Hi-Tech Pharmacal's Tropazone dermatitis treatment

Pfizer and Debiopharm to initiate phase III trial of tremelimumab in stage IV melanoma

Amira develops solid-dose formulations of FLAP inhibitors

FDA approves Chugai's monoclonal antibody Actemra for moderate to severe RA

Sanofi and KaloBios sign agreement for Humaneered antibody for P. aeruginosa

FDA grants orphan drug designation to Clavis's CP-4126 for pancreatic cancer

Boston Scientific granted Japanese marketing approval for Promus coronary stent system

Delay in FDA review of MannKind's NDA for Afrezza

Study determines pharmacokinetics of HCV candidate ABT-333 in infected patients

Hepatitis C treatment SPC-3649 to enter phase II investigation this year

In vitro data clarify mechanism of action of HCV candidate ATI-0810

AstraZeneca claims fumarate salts of ErbB kinase inhibitors for cancer therapy

Budesonide derivatives presented by Auspex Pharmaceuticals

Celgene describes novel thioxoisoidoline compounds for the treatment of cancer

GSK discloses novel prostanoid EP4 receptor agonists for pain, bone disorders

TetraLogic commences phase I TL-32711 trial in solid tumors or lymphoma

First patient dosed in phase III PLX-4032 trial in metastatic melanoma

Funxional Therapeutics completes phase I FX-125L program

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...